ONSANDA
LIVE

Serial Number

79205575

Owner

NOVARTIS AG

Filing Date

Jan 6, 2017

Add to watchlist:

No watchlists yet
View on USPTO

ONSANDA Trademark

Serial Number: 79205575 • Registration: 5268602

ONSANDA is a trademark filed by NOVARTIS AG on January 6, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

January 6, 2017

Registration Date

August 22, 2017

Published for Opposition

June 6, 2017

Cancellation Date

September 9, 2020

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 21, 2022 FINV
REFUSAL PROCESSED BY IB
Jan 30, 2021 RFNT
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Sep 25, 2020 DENC
DEATH OF INTERNATIONAL REGISTRATION
Sep 25, 2020 DETH
NOTIFICATION PROCESSED BY IB
Oct 13, 2017 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Sep 27, 2017 FICS
FINAL DISPOSITION PROCESSED
Sep 27, 2017 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Sep 21, 2017 GPAR
REGISTERED-PRINCIPAL REGISTER
Aug 22, 2017 R.PR
PUBLISHED FOR OPPOSITION
Jun 6, 2017 PUBO
NOTICE OF PUBLICATION
May 17, 2017 NPUB
APPLICATION FILING RECEIPT MAILED
May 2, 2017 MAFR
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 29, 2017 CNSA
ASSIGNED TO EXAMINER
Apr 27, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 27, 2017 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Apr 21, 2017 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 20, 2017 REPR